person

Nina M.

Country
Germany
Department
40177: Hautklinik

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
477
Sites with multiple studies

Has run more than one trial at 477 of 773 partner sites.

Specializations

Inflammatory Skin Conditions

The investigator specializes in treating chronic inflammatory skin disorders, with particular emphasis on atopic dermatitis and plaque psoriasis. Their research encompasses both adult and pediatric populations affected by these conditions.

  • Moderate to severe atopic dermatitis management
  • Plaque psoriasis treatment approaches
  • Pediatric dermatological care

Their work includes evaluating novel therapeutic agents and long-term treatment strategies for inflammatory skin conditions.

Autoimmune Skin Disorders

The investigator focuses on treating various autoimmune skin conditions, including bullous pemphigoid, vitiligo, and alopecia areata. Their expertise extends to both conventional and innovative treatment approaches.

  • Non-segmental vitiligo treatment
  • Alopecia areata management
  • Bullous pemphigoid therapy

Their research involves investigating targeted therapies for autoimmune dermatological conditions.

Complex Dermatological Conditions

The investigator has developed expertise in treating hidradenitis suppurativa and other complex dermatological disorders. Their work includes evaluation of novel biological therapies and treatment protocols.

  • Hidradenitis suppurativa management
  • Long-term disease control strategies
  • Innovative therapeutic approaches

Their research encompasses both monotherapy and combination treatment approaches for challenging dermatological conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.